MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis
MAX dimerization protein 3 (MXD3), a transcriptional regulator of the MXD3 superfamily, is a part of the MYC–MAX–MXD network. However, its role in tumors has been reported in several cancers, such as B-cell acute lymphoblastic leukemia, medulloblastoma, neuroblastoma, and glioblastoma. Based on TCGA...
Enregistré dans:
Auteurs principaux: | Xiaoyu Zhang, Xiaoqin He, Yue Li, Yangtao Xu, Wenliang Chen, Xin Liu, Xinyao Hu, Lin Xiong, Ximing Xu |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/03a918ac26324d8abc5c93749ca89d8d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
LRMP Associates With Immune Infiltrates and Acts as a Prognostic Biomarker in Lung Adenocarcinoma
par: Xin Jin, et autres
Publié: (2021) -
Prognostic role of oxytocin receptor in colon adenocarcinoma
par: Sun Junjie, et autres
Publié: (2021) -
Prognostic Implications and Immune Infiltration Analysis of ALDOA in Lung Adenocarcinoma
par: Guojun Lu, et autres
Publié: (2021) -
Methylation and Expression of the Exercise-Related TLR1 Gene Is Associated With Low Grade Glioma Prognosis and Outcome
par: Lichun Lu, et autres
Publié: (2021) -
Identification of a Pyroptosis-Related Gene Signature for Predicting Overall Survival and Response to Immunotherapy in Hepatocellular Carcinoma
par: Susu Zheng, et autres
Publié: (2021)